Form 4: Celanese Director Acquires Phantom Stock via Deferred Plan

Sentiment:

Insider Transaction Report


Celanese Director Deborah J. Kissire is set to acquire 4.54 shares of phantom stock on November 12, 2025, as dividend equivalents under a deferred compensation plan.

Summary

  • Deborah J. Kissire, a Director of Celanese Corp (CE), is the reporting person for this transaction.
  • The transaction involves the acquisition of 4.54 shares of phantom stock.
  • This phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan.
  • The transaction is scheduled to occur on November 12, 2025.
  • Following this transaction, Ms. Kissire will beneficially own 5,921.288 shares of phantom stock.
  • Each share of phantom stock represents the right to receive one share of Celanese Common Stock.
  • The phantom stock becomes payable in shares of Common Stock following the termination of Ms. Kissire's service as a director.
  • The derivative security (phantom stock) was valued at $39.12 for this transaction.
  • The transaction is being made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled insider transaction related to director compensation, which is generally a neutral to slightly positive event as it reflects ongoing director involvement and alignment of interests.

Positives

  • The acquisition of phantom stock as dividend equivalents indicates ongoing compensation for the director, aligning their interests with long-term shareholder value.
  • The transaction is part of a pre-arranged Rule 10b5-1 plan, demonstrating a structured and non-discretionary approach to insider stock activity.

Future Outlook

The phantom stock acquired is scheduled to become payable in shares of Common Stock following the termination of Deborah J. Kissire's service as a director of the Company. The transaction itself is scheduled for November 12, 2025, as part of a pre-arranged Rule 10b5-1 plan.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically related to director compensation. Such filings are common across all publicly traded companies and provide transparency into executive and director stock ownership changes, often linked to compensation plans or pre-scheduled trading arrangements like Rule 10b5-1 plans.

Stakeholder Impact

  • Shareholders: Provides transparency regarding director compensation and beneficial ownership, indicating continued alignment of director interests with the company's performance.
  • Employees: No direct impact mentioned.

Next Steps

  • The phantom stock will become payable in shares of Common Stock following the termination of the reporting person's service as a director of the Company.

Key Dates

DateDescription
11/12/2025Date of the scheduled transaction for the acquisition of phantom stock.
11/13/2025Date the Form 4 was signed and filed.

Keywords

Celanese Corp, CE, Phantom Stock, Insider Trading, Form 4, Deferred Compensation, Director Compensation, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.